FDA reconsiders COVID-19 booster approvals, with Makary emphasizing the need for “good data”

(NaturalNews) The FDA is reconsidering its approach to COVID-19 vaccine approvals for the upcoming season, citing insufficient data on booster effectiveness...

May 4, 2025 - 02:56
 0
FDA reconsiders COVID-19 booster approvals, with Makary emphasizing the need for “good data”
(NaturalNews) The FDA is reconsidering its approach to COVID-19 vaccine approvals for the upcoming season, citing insufficient data on booster effectiveness...